Qilian International Holding Group Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.796
- Today's High:
- $0.7966
- Open Price:
- $0.7966
- 52W Low:
- $0.6832
- 52W High:
- $2.0767
- Prev. Close:
- $0.796
- Volume:
- 787
Company Statistics
- Market Cap.:
- $28.96 million
- Book Value:
- 1.478
- Revenue TTM:
- $61.93 million
- Operating Margin TTM:
- 1.75%
- Gross Profit TTM:
- $6.23 million
- Profit Margin:
- 2.4%
- Return on Assets TTM:
- 0.94%
- Return on Equity TTM:
- 2.77%
Company Profile
Qilian International Holding Group Ltd had its IPO on 2021-01-12 under the ticker symbol QLI.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Qilian International Holding Group Ltd has a staff strength of 345 employees.
Stock update
Shares of Qilian International Holding Group Ltd opened at $0.8 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.8 - $0.8, and closed at $0.8.
This is a +0.01% increase from the previous day's closing price.
A total volume of 787 shares were traded at the close of the day’s session.
In the last one week, shares of Qilian International Holding Group Ltd have increased by +0.01%.
Qilian International Holding Group Ltd's Key Ratios
Qilian International Holding Group Ltd has a market cap of $28.96 million, indicating a price to book ratio of 0.7088 and a price to sales ratio of 0.6094.
In the last 12-months Qilian International Holding Group Ltd’s revenue was $61.93 million with a gross profit of $6.23 million and an EBITDA of $1.97 million. The EBITDA ratio measures Qilian International Holding Group Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Qilian International Holding Group Ltd’s operating margin was 1.75% while its return on assets stood at 0.94% with a return of equity of 2.77%.
In Q1, Qilian International Holding Group Ltd’s quarterly earnings growth was a positive 464.3% while revenue growth was a negative 9.1%.
Qilian International Holding Group Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 27
- PEG
Its diluted EPS in the last 12-months stands at $0.03 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Qilian International Holding Group Ltd’s profitability.
Qilian International Holding Group Ltd stock is trading at a EV to sales ratio of 0.6846 and a EV to EBITDA ratio of 12.3533. Its price to sales ratio in the trailing 12-months stood at 0.6094.
Qilian International Holding Group Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 1.67%.
Balance sheet and cash flow metrics
- Total Assets
- $64.53 million
- Total Liabilities
- $9.18 million
- Operating Cash Flow
- $-1719182.00
- Capital Expenditure
- $1.78 million
- Dividend Payout Ratio
- 1.67%
Qilian International Holding Group Ltd ended 2024 with $64.53 million in total assets and $0 in total liabilities. Its intangible assets were valued at $64.53 million while shareholder equity stood at $53.05 million.
Qilian International Holding Group Ltd ended 2024 with $0 in deferred long-term liabilities, $9.18 million in other current liabilities, 59583.00 in common stock, $15.51 million in retained earnings and $0 in goodwill. Its cash balance stood at $14.32 million and cash and short-term investments were $14.32 million. The company’s total short-term debt was $1,696,086 while long-term debt stood at $0.
Qilian International Holding Group Ltd’s total current assets stands at $30.03 million while long-term investments were $20.33 million and short-term investments were $0. Its net receivables were $4.87 million compared to accounts payable of $5.29 million and inventory worth $8.88 million.
In 2024, Qilian International Holding Group Ltd's operating cash flow was $-1719182.00 while its capital expenditure stood at $1.78 million.
Comparatively, Qilian International Holding Group Ltd paid $0.02 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.8
- 52-Week High
- $2.0767
- 52-Week Low
- $0.6832
- Analyst Target Price
- $
Qilian International Holding Group Ltd stock is currently trading at $0.8 per share. It touched a 52-week high of $2.0767 and a 52-week low of $2.0767. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.83 and 200-day moving average was $1.09 The short ratio stood at 1.42 indicating a short percent outstanding of 0%.
Around 7744.6% of the company’s stock are held by insiders while 7.6% are held by institutions.
Frequently Asked Questions About Qilian International Holding Group Ltd
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil’s chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People’s Republic of China.